FLXBIO.COM

parksquare.com

Life Sciences - Park Square Executive Search

http://www.parksquare.com/expertise/life-sciences

Advanced Materials and Renewable Energy. Advanced Materials and Renewable Energy. Executive Director, Business Development. Vice President, Manufacturing. Vice President, Quality Assurance. Associate Entrepreneur in Residence. Genomic Informatics Partner, Healthcare Services. Senior Vice President, Public Affairs Vice President, Marketing. Senior Vice President, Operations. President and Chief Executive Officer. Vice President, Communications. Vice President, Global Sales. Vice President, Marketing.

parksquare.com

Advanced Materials and Renewable Energy - Park Square Executive Search

http://www.parksquare.com/expertise/test/cleantech

Advanced Materials and Renewable Energy. Advanced Materials and Renewable Energy. Advanced Materials and Renewable Energy. Vice President, Engineering. Vice President, Sales. Vice President, Operations. Vice President, Aquaculture. Vice President, Sales. General Manager, Specialty Chemicals. Senior Vice President, Human Resources. Vice President, Research and Development. Chief Financial Officer, Asia. Vice President, Business Development. Vice President, Marketing. Senior Vice President, Manufacturing.

parksquare.com

Education - Park Square Executive Search

http://www.parksquare.com/expertise/test/education

Advanced Materials and Renewable Energy. Advanced Materials and Renewable Energy. For a list of relevant searches, please click here. Dean, Herberger College of Fine Arts. Director, School of Art. Director, School of Music. Berklee College of Music. Chief Marketing Officer, BerkleeMusic. Senior Vice President, Institutional Advancement. Dean, School of Law. Chief Radiation Safety Officer. Executive Director, Clinical Trials Office. Executive Director, Sponsored Projects Administration. Dean, Student Life.

thecolumngroup.com

Healthcare Venture Capital Investing in Early Stage Biotechnology Companies | The Column Group - TCG

http://www.thecolumngroup.com/neurona-therapeutics-closes-24-million-in-series-a-financing/index.html

TCG is a science-driven venture capital firm focused on nurturing a select group of early stage drug discovery companies with unique scientific platforms that can change the world. The Column Group (TCG) is a science-driven venture capital firm that makes significant financial and operational commitments to build early stage drug discovery companies based on their unique scientific platforms and potential to deliver multiple breakthrough therapeutics. TCG is about the bold pursuit of big ideas using inno...

thecolumngroup.com

Healthcare Venture Capital Investing in Early Stage Biotechnology Companies | The Column Group - TCG

http://www.thecolumngroup.com/seragon-is-acquired-by-genentech-for-up-to-1-725-billion/index.html

TCG is a science-driven venture capital firm focused on nurturing a select group of early stage drug discovery companies with unique scientific platforms that can change the world. The Column Group (TCG) is a science-driven venture capital firm that makes significant financial and operational commitments to build early stage drug discovery companies based on their unique scientific platforms and potential to deliver multiple breakthrough therapeutics. TCG is about the bold pursuit of big ideas using inno...

thecolumngroup.com

Healthcare Venture Capital Investing in Early Stage Biotechnology Companies | The Column Group - TCG

http://www.thecolumngroup.com/index.html

TCG is a science-driven venture capital firm focused on nurturing a select group of early stage drug discovery companies with unique scientific platforms that can change the world. The Column Group (TCG) is a science-driven venture capital firm that makes significant financial and operational commitments to build early stage drug discovery companies based on their unique scientific platforms and potential to deliver multiple breakthrough therapeutics. TCG is about the bold pursuit of big ideas using inno...

thecolumngroup.net

Healthcare Venture Capital Investing in Early Stage Biotechnology Companies | The Column Group - TCG

http://www.thecolumngroup.net/neurona-therapeutics-closes-24-million-in-series-a-financing/index.html

TCG is a science-driven venture capital firm focused on nurturing a select group of early stage drug discovery companies with unique scientific platforms that can change the world. The Column Group (TCG) is a science-driven venture capital firm that makes significant financial and operational commitments to build early stage drug discovery companies based on their unique scientific platforms and potential to deliver multiple breakthrough therapeutics. TCG is about the bold pursuit of big ideas using inno...